Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory  conditions

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

4.9
(771)
Write Review
More
$ 20.00
Add to Cart
In stock
Description

In a recent bioRxiv paper, a research group from the Marinomed Biotech biopharmaceutical company in Austria showed that a sulfated polysaccharide iota-carrageenan has the propensity to inhibit cell entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using an in vitro neutralization assay.

Carrageenan nasal spray may double the rate of recovery from

Sulfated polysaccharides as multi target molecules to fight COVID

Antiviral activity of lambda-carrageenan against influenza viruses

Exploring algae and cyanobacteria as a promising natural source of

Biosensors, Free Full-Text

Nanotechnology-driven improvisation of red algae-derived

Small molecules in the treatment of COVID-19

PDF) Efficacy of a Nasal Spray Containing Iota-Carrageenan in the

Cuáles son algunas adaptaciones de las algas?

Carbohydrates-based diagnosis, prophylaxis and treatment of

Nutraceuticals, Free Full-Text

Frontiers Can Algal Derived Bioactive Metabolites Serve as